GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q3 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $195.1 million versus the consensus estimate of $194.89 million.

GUIDANCE:

GoodRx Holdings, Inc. sees Q4 2021 revenue of $212-222 million, versus the consensus of $217 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.